Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

What we do

The Division of Health Economics contributes to...

...the exploration of the conceptual underpinnings of the logic of cost effectiveness,

...the development of advanced evaluation paradigms,

...better understanding of the social value of health care programs.

In order to support these objectives, the research program is based upon three pillars, namely:

  • Burden of disease studies,
    addressing cancer related burden of disease, attributable cost of illness, and budget impact of interventions, from the perspectives of society as a whole as well as those of payers and patients (focusing on but not limited to Germany);
  • Cost value analyses,
    evaluating the cost effectiveness of clinical intervention strategies in cancer care, ranging from new institutional settings (such as comprehensive cancer centers) to novel developments, including the anticipated spread of targeted therapy;
  • Economic methods and Social Costs Value Analysis (SCVA),
    contributing to the further improvement of economic evaluation methods within the currently prevailing paradigm of cost effectiveness analyses, and actively participating in the development of health economic evaluation methods designed to better reflect social norms and emphasis on cancer care.

The research program has been complemented by initiatives specifically designed to disseminate new insights, i.e., in effect, a fourth pillar:

to top
powered by webEdition CMS